JournoLink uses cookies JournoLink requires cookies to function. You can read more in our Privacy Policy

Professor John Celin

Prof. of Plastic Surgery urges fellow UK surgeons to recall patients in view of the increasing number of reports in the US of treatable Breast Lymphoma

14 September 2017 13:21

FOR IMMEDIATE RELEASE

Professor Of Plastic Surgery And Over 30 Years In The Industry Urges Patients and Plastic Surgeons In The UK To Follow the US Counterparts Lead By Recalling Patients Who May Be Affected By Implants That May Lead To Treatable Cancer...

In support of the findings from the FDA published on the front page of The New York Times (May 13-14 2017), Professor John Celin, who runs a clinic off London’s Harley Street is calling on fellow surgeons in the UK to reach out to patients who may be affected by the Lymphoma.

“It’s going to take some time but I am contacting each of my implant patients from over the years and suggesting they get their breasts professionally checked. If detected early the cancer is often curable. It is our duty of care to ensure patients are notified of any risks and are given the same level of care following a procedure as they are before. There are too many ‘cosmetic surgeons’ with minimal qualifications and little in the way of professional integrity or pastoral care who will not be taking any action on hearing this report and that’s incredibly depressing”. Comments Celin.

Everyone should regularly check their breasts for lumps, unusual marks, swelling or pain anyway but my suggestion would be that those with implants should contact their surgeon for an additional thorough check over.

The US Food and Drug Administration have received numerous of implant associated Lymphoma, however to date very few patients have been informed of this latest report and with 1.4 million implant patients in 2015 it’s important to raise the profile of this risk.

Professor Celin is due to travel to the US to lecture on the latest findings from the FDA.

KEY FACTS
• Most cancer develops 2-20 years after surgery with a median of 8 years.
• The vast majority of detected cancer tends to be in those patients with texture impants and silicone doesn’t seem to make any difference – despite some mis-leading press reports.
• The cancer has not been directly attributed to the implants and no implants have been recalled
• There are 10 million people with implants in the world.


Download as PDF | Report this press release


Attached Images


Press Contacts

Emma Knewstub

Marketing & PR

Tel: 07834760627

Email: info@drjohncelin.com


About Professor John Celin

John F. Celin M.D, is a former Clinical Fellow at the Department of Surgery, Harvard Medical School. Following training and Board Certification in General and Vascular surgery, Prof. Celin trained in Reconstructive Plastic Surgery at the Harvard Medical School, New York University and University of Kentucky.
He continued his training in Cosmetic Surgery under Tom D Rees M.D. at The Manhattan Eye, Ear and Throat Hospital, New York Medical Center.
Prof. Celin is a clinical Associate Professor at The Department of Plastic Surgery at the University of Virginia, School of Medicine, Consultant faculty.
Besides his work as a surgeon in the UK and US, commitment to patients of the Third World is incredibly important. Prof. Celin regularly spends several months a year providing humanitarian aid in countries such as Pakistan, India and the Dominican Republic.
www.drjohncelin.com

www.drjohncelin.com

View JournoLink Profile

Share

Share to Facebook Share to Twitter Share to LinkedIn

More from Professor John Celin



Journalists...

For more information on JournoLink and how to receive more content like this, please visit https://journolink.com/journalists.